Vivo Capital, LLC Diversified Active

Location: Palo Alto, CA

CIK: 0001674712 · Show all filings

Period: Q2 2018 (← Previous) (Next →)

Filing Date: Aug 10, 2018

Total Value: $776M (100.0% shares, 0.0% debt)

Holdings (40)

ASND Ascendis Pharma 18.6%

Value $144M Shares 2,166,832 Est. Cost $26.35 Unrealized —

— Biohaven Pharmaceutical Holding Company Ltd 10.4%

Value $81M Shares 2,049,545 Est. Cost $36.97 Unrealized —

— Kadmon Holdings (KDMN) 8.9%

Value $68.92M Shares 10,454,545 Est. Cost $5.56 Unrealized —

CDXS Codexis, Inc. 5.7%

Value $43.99M Shares 3,054,825 Est. Cost $3.85 Unrealized +238.3%

ACRS Aclaris Therapeutics 4.2%

Value $32.9M Shares 1,647,214 Est. Cost $19.11 Unrealized -3.3%

— Menlo Therapeutics 4.2%

Value $32.57M Shares 4,011,236 Est. Cost $37.58 Unrealized —

APLS Apellis Pharmaceuticals, Inc. 4.1%

Value $32.04M Shares 1,456,499 Est. Cost $14.72 Unrealized +56.1%

— Tricida, Inc. 3.8%

Value $29.65M Shares 991,711 Est. Cost $29.90 Unrealized —

— Homology Medicines, Inc. 3.7%

Value $28.76M Shares 1,409,742 Est. Cost $19.00 Unrealized —

— MEI Pharma Inc (NAS) 3.4%

Value $26.01M Shares 6,600,660 Est. Cost $3.94 Unrealized —

ARWR Arrowhead Pharmaceuticals In 3.3%

Value $25.84M Shares 1,900,000 Est. Cost $6.16 Unrealized +51.8%

— Eiger BioPharmaceuticals 2.8%

Value $21.85M Shares 1,791,257 Est. Cost $16.42 Unrealized —

— Amyris, Inc. 2.3%

Value $18.06M Shares 2,826,711 Est. Cost $3.20 Unrealized —

MDGL Madrigal Pharmaceuticals Inc 2.2%

Value $17.4M Shares 62,220 Est. Cost $152.78 Unrealized +14.9%

— Kala Pharmaceuticals, Inc. 1.8%

Value $14.32M Shares 1,043,020 Est. Cost $22.84 Unrealized —

— Nabriva Therapeutics Plc 1.8%

Value $14.18M Shares 4,074,190 Est. Cost $8.19 Unrealized —

— Obseva SA 1.8%

Value $14.01M Shares 925,000 Est. Cost $15.14 Unrealized —

— Cymabay Therapeutics inc 1.6%

Value $12.16M Shares 906,000 Est. Cost $13.04 Unrealized —

— Strongbridge Biopharma plc 1.5%

Value $11.51M Shares 1,918,132 Est. Cost $2.40 Unrealized —

— Selecta Biosciences, Inc. 1.3%

Value $10.34M Shares 780,601 Est. Cost $19.86 Unrealized —

— Soleno Therapeutics, Inc. 1.3%

Value $10.2M Shares 4,359,683 Est. Cost $1.84 Unrealized —

— Deciphera Pharmaceuticals In 1.3%

Value $9.953M Shares 252,942 Est. Cost $39.35 Unrealized —

— Galmed Pharmaceuticals Ltd 1.2%

Value $9.433M Shares 792,707 Est. Cost $11.90 Unrealized —

— Zymeworks Inc 1.2%

Value $9.166M Shares 620,134 Est. Cost $14.78 Unrealized —

— Sierra Oncology, Inc 0.9%

Value $7.217M Shares 2,438,270 Est. Cost $1.55 Unrealized —

— Genocea Biosciences Inc(NMS) 0.9%

Value $7M Shares 8,180,000 Est. Cost $1.05 Unrealized —

AUPH Aurinia Pharmaceuticals Inc. 0.9%

Value $6.831M Shares 1,213,290 Est. Cost $5.62 Unrealized -0.7%

RGNX Regenxbio Inc. 0.8%

Value $5.912M Shares 82,403 Est. Cost $12.80 Unrealized +273.1%

ZLAB Zai Lab LTD 0.7%

Value $5.371M Shares 231,010 Est. Cost $27.00 Unrealized —

— Zogenix, Inc. 0.6%

Value $4.641M Shares 105,000 Est. Cost $40.05 Unrealized —

— Foamix Pharmaceuticals Ltd. 0.6%

Value $4.284M Shares 855,000 Est. Cost $9.26 Unrealized —

— BioPharmX Corporation 0.5%

Value $3.561M Shares 16,128,515 Est. Cost $0.36 Unrealized —

— Kiniksa Pharmaceuticals-A 0.4%

Value $3.228M Shares 186,073 Est. Cost $17.35 Unrealized —

— Verona Pharma Plc 0.4%

Value $2.792M Shares 1,492,951 Est. Cost $13.61 Unrealized —

— Trevena, Inc. 0.3%

Value $2.488M Shares 1,728,000 Est. Cost $7.67 Unrealized —

KALV KalVista Pharmaceuticals, Inc. 0.3%

Value $2.439M Shares 300,325 Est. Cost $7.13 Unrealized +23.9%

— Agile Therapeutics, Inc. 0.1%

Value $742K Shares 1,513,975 Est. Cost $6.21 Unrealized —

— Akari Therapeutics Plc 0.1%

Value $674K Shares 345,850 Est. Cost $14.00 Unrealized —

— Sunesis Pharmaceuticals, Inc. 0.1%

Value $414K Shares 195,474 Est. Cost $3.62 Unrealized —

— Soleno Therapeutics, Inc. 0.0%

Value $79,000 Shares 188,772 Est. Cost $0.14 Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
ASND	Ascendis Pharma	2,166,832	$144M	18.6%	$26.35	—	ADR	04351P101
—	Biohaven Pharmaceutical Holding Company Ltd	2,049,545	$81M	10.4%	$36.97	—	Common	G11196105
—	Kadmon Holdings (KDMN)	10,454,545	$68.92M	8.9%	$5.56	—	Common	48283N106
CDXS	Codexis, Inc.	3,054,825	$43.99M	5.7%	$3.85	+238.3%	Common	192005106
ACRS	Aclaris Therapeutics	1,647,214	$32.9M	4.2%	$19.11	-3.3%	Common	00461U105
—	Menlo Therapeutics	4,011,236	$32.57M	4.2%	$37.58	—	Common	586858102
APLS	Apellis Pharmaceuticals, Inc.	1,456,499	$32.04M	4.1%	$14.72	+56.1%	Common	03753U106
—	Tricida, Inc.	991,711	$29.65M	3.8%	$29.90	—	Common	89610F101
—	Homology Medicines, Inc.	1,409,742	$28.76M	3.7%	$19.00	—	Common	438083107
—	MEI Pharma Inc (NAS)	6,600,660	$26.01M	3.4%	$3.94	—	Common	55279B202
ARWR	Arrowhead Pharmaceuticals In	1,900,000	$25.84M	3.3%	$6.16	+51.8%	Common	04280A100
—	Eiger BioPharmaceuticals	1,791,257	$21.85M	2.8%	$16.42	—	Common	28249U105
—	Amyris, Inc.	2,826,711	$18.06M	2.3%	$3.20	—	Common	03236M200
MDGL	Madrigal Pharmaceuticals Inc	62,220	$17.4M	2.2%	$152.78	+14.9%	Common	558868105
—	Kala Pharmaceuticals, Inc.	1,043,020	$14.32M	1.8%	$22.84	—	Common	483119103
—	Nabriva Therapeutics Plc	4,074,190	$14.18M	1.8%	$8.19	—	SHS	G63637105
—	Obseva SA	925,000	$14.01M	1.8%	$15.14	—	Common	H5861P103
—	Cymabay Therapeutics inc	906,000	$12.16M	1.6%	$13.04	—	Common	23257D103
—	Strongbridge Biopharma plc	1,918,132	$11.51M	1.5%	$2.40	—	SHS USD	G85347105
—	Selecta Biosciences, Inc.	780,601	$10.34M	1.3%	$19.86	—	Common	816212104
—	Soleno Therapeutics, Inc.	4,359,683	$10.2M	1.3%	$1.84	—	Common	834203200
—	Deciphera Pharmaceuticals In	252,942	$9.953M	1.3%	$39.35	—	Common	24344T101
—	Galmed Pharmaceuticals Ltd	792,707	$9.433M	1.2%	$11.90	—	SHS	M47238106
—	Zymeworks Inc	620,134	$9.166M	1.2%	$14.78	—	Common	98985W102
—	Sierra Oncology, Inc	2,438,270	$7.217M	0.9%	$1.55	—	Common	82640U107
—	Genocea Biosciences Inc(NMS)	8,180,000	$7M	0.9%	$1.05	—	Common	372427104
AUPH	Aurinia Pharmaceuticals Inc.	1,213,290	$6.831M	0.9%	$5.62	-0.7%	Common	05156V102
RGNX	Regenxbio Inc.	82,403	$5.912M	0.8%	$12.80	+273.1%	Common	75901B107
ZLAB	Zai Lab LTD	231,010	$5.371M	0.7%	$27.00	—	ADR	98887Q104
—	Zogenix, Inc.	105,000	$4.641M	0.6%	$40.05	—	Common	98978L204
—	Foamix Pharmaceuticals Ltd.	855,000	$4.284M	0.6%	$9.26	—	SHS	M46135105
—	BioPharmX Corporation	16,128,515	$3.561M	0.5%	$0.36	—	Common	09072X101
—	Kiniksa Pharmaceuticals-A	186,073	$3.228M	0.4%	$17.35	—	Common	G5269C101
—	Verona Pharma Plc	1,492,951	$2.792M	0.4%	$13.61	—	ADS	925050106
—	Trevena, Inc.	1,728,000	$2.488M	0.3%	$7.67	—	Common	89532E109
KALV	KalVista Pharmaceuticals, Inc.	300,325	$2.439M	0.3%	$7.13	+23.9%	Common	483497103
—	Agile Therapeutics, Inc.	1,513,975	$742K	0.1%	$6.21	—	Common	00847L100
—	Akari Therapeutics Plc	345,850	$674K	0.1%	$14.00	—	ADR	00972G108
—	Sunesis Pharmaceuticals, Inc.	195,474	$414K	0.1%	$3.62	—	Common Par	867328700
—	Soleno Therapeutics, Inc.	188,772	$79,000	0.0%	$0.14	—	Warrant	834203135